Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts.
Saved in:
| Title: | Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts. |
|---|---|
| Authors: | Jahan, Farhana1 (AUTHOR), Penna, Leena2 (AUTHOR), Luostarinen, Annu2 (AUTHOR), Veltman, Laurens1 (AUTHOR), Hongisto, Heidi2 (AUTHOR), Lähteenmäki, Kaarina3 (AUTHOR), Müller, Sabine4 (AUTHOR), Ylä-Herttuala, Seppo5 (AUTHOR), Korhonen, Matti1 (AUTHOR), Vettenranta, Kim1,6 (AUTHOR), Laitinen, Anita2 (AUTHOR), Salmenniemi, Urpu7 (AUTHOR), Kerkelä, Erja2 (AUTHOR) erja.kerkela@bloodservice.fi |
| Source: | Scientific Reports. 11/4/2024, Vol. 14 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
